Lupin Pharmaceuticals Inc. recalls Bimatoprost Ophthalmic Solution 0.03%, packaged in a) 5 mL (NDC 68180-429-02) and b) 7.5 mL (NDC 68180-429-03) bottles,
Lupin Pharmaceuticals recalls 0.03% Bimatoprost Ophthalmic Solution in 5mL and 7.5mL bottles due to impurities. This may cause eye irritation or other issues. Stop using and contact for replacement.
Lower-risk recall
Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities.
Contact the company & request your remedy
What happened, in plain English
Lupin Pharmaceuticals is recalling 0.03% Bimatoprost Ophthalmic Solution in 5mL and 7.5mL bottles because impurities were found. This could cause eye irritation or other issues if used. Read more at govinfonow.com/recall/39227-lupin-bimatoprost-ophthalmic-solution-0-03-recall-impurities-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39227-lupin-bimatoprost-ophthalmic-solution-0-03-recall-impurities-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0429-2019
Cite this page
“Lupin Bimatoprost Ophthalmic Solution 0.03% Recall: Impurities Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39227-lupin-bimatoprost-ophthalmic-solution-0-03-recall-impurities-risk. Based on FDA recall #D-0429-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0429-2019%22&limit=1).
Why it’s dangerous
The product contains impurities that may cause eye irritation or other issues. These impurities were detected during quality testing and could affect the product's safety.
Who’s affected
People with prescriptions for Bimatoprost Ophthalmic Solution 0.03% from Lupin Pharmaceuticals. Those using the product for glaucoma or eye pressure are most at risk.
How to tell if you have this one
Check for 5mL bottles (NDC 68180-429-02) or 7.5mL bottles (NDC 68180-429-03) with expiration dates listed on the label.
- Brand
Lupin Pharmaceuticals- Category
Drug
What to do — step by step
Stop Using Now
Discontinue use of the recalled Bimatoprost Ophthalmic Solution 0.03% products immediately.
Questions people ask
Is this product safe to use?
The product has been recalled due to impurities detected during quality testing, which may cause eye irritation or other issues. Do not use.
What should I do if I have this product?
Stop using it immediately and contact your doctor or pharmacy for a replacement.
How can I check if I have the recalled product?
Look for 5mL bottles (NDC 68180-429-02) or 7.5mL bottles (NDC 68180-429-03) with expiration dates listed on the label.
Contact Lupin Pharmaceuticals
We’ve drafted a message you can send Lupin Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0429-2019 — Lupin Pharmaceuticals Lupin Pharmaceuticals Hello, I own a Lupin Pharmaceuticals that is covered by recall D-0429-2019 from Lupin Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0429-2019 (January 28, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0429-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.